Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |